Sp3 and Sp4 Transcription Factor Levels Are Increased in Brains of Patients with Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1660-2862|4|6|413-423

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.4, Iss.6, 2007-10, pp. : 413-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization and promoter analysis of the mouse gene for transcription factor Sp4

By Song J.   Mangold M.   Suske G.   Geltinger C.   Kanazawa I.   Sun K.   Yokoyama K.K.  

Gene, Vol. 264, Iss. 1, 2001-02 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Homocysteine May Contribute to Pathogenesis of RNA Damage in Brains with Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 6, Iss. 5-6, 2009-11 ,pp. : 252-257

Karger

Access to resources Recommend Favorite

Plasmin Deficiency in Alzheimer’s Disease Brains: Causal or Casual?

By  

Neurodegenerative Diseases, Vol. 1, Iss. 4-5, 2004-11 ,pp. : 205-212

Karger

Access to resources Recommend Favorite

Neuronal Expression of F-Box and Leucine-Rich-Repeat Protein 2 Decreases over Braak Stages in the Brains of Alzheimer’s Disease Patients

By  

Neurodegenerative Diseases, Vol. 11, Iss. 1, 2012-03 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 403-405

Karger

Access to resources Recommend Favorite